Treatment of Vaginal Lichen Planus

First-Line Treatment Regimen

The British Journal of Dermatology recommends clobetasol propionate 0.05% ointment applied once daily for 4 weeks, then on alternate days for 4 weeks, followed by twice weekly for 4 weeks 1, 2, 3
A soap substitute should be used instead of regular soap products, and a barrier preparation should be applied to protect the affected area 2
All irritants and fragranced products should be avoided as they may exacerbate the condition 2
A 30g tube of clobetasol propionate should last approximately 12 weeks when used appropriately 1, 3
Patients should be instructed on proper application technique and safe use of ultrapotent topical steroids 2

All patients should be reviewed after the initial 12-week treatment period to assess response 2, 3
If treatment has been successful, hyperkeratosis, ecchymoses, fissuring, and erosions should resolve, though atrophy and color changes may persist 1, 3
For ongoing active disease, continued use of clobetasol propionate 0.05% is recommended as needed 2
Most patients with ongoing disease require approximately 30-60g of clobetasol propionate annually 1, 3
Long-term use of clobetasol propionate in this manner has been shown to be safe without significant steroid-related damage 3

For steroid-resistant hyperkeratotic areas, consider intralesional triamcinolone (10-20mg) after excluding malignancy by biopsy 2, 3
Caution should be exercised with calcineurin inhibitors due to concerns about increased risk of neoplasia in a disease with premalignant potential 5

For introital narrowing, surgical intervention may be necessary, using part of the posterior vaginal wall in reconstruction to prevent further adhesions 6
For dyspareunia or psychosexual issues, referral to appropriate specialists should be considered 6
For neuropathic pain (vestibulodynia/vulvodynia) that persists despite clinical improvement, consider xylocaine 5% ointment or amitriptyline 6

Inadequate duration of initial treatment: ensure a full 12-week course before declaring treatment failure 3
Abrupt discontinuation of topical steroids: always taper gradually to prevent rebound flares 3
Failure to consider alternative diagnoses in treatment-resistant cases: perform a biopsy to confirm diagnosis when response is poor 2
Testosterone and other hormones: despite historical use, there is no evidence base for the use of topical testosterone in vaginal lichen planus 3
Patients should be advised that while symptoms and active inflammation can improve with treatment, complete resolution of all skin changes may not occur 3

In cases of severe disease not responding to conventional therapy, referral to a specialist vulval clinic is recommended 2